The long-term objective of my lab is to obtain mechanistic insights into the role of aneuploidy in tumorogenesis. Our current focus on studying the key mechanical and regulatory events that specify accurate chromosome segregation in human cells is of direct importance towards understanding mechanisms that cause cancer and for the development of novel approaches to kill cancer cells. We have focused on identifying and characterizing the molecular components of the kinetochore as a majo[ effort towards understanding the molecular requirements for accurate chromosome segregation. The goals of this proposal are to examine how some of these proteins work together to make a functional kinetochore that links kinetochore:microtubule interactions to the mitotic checkpoint pathway. We will use molecular, biochemical and microscopic approaches to accomplish our goals. This proposal will focus on the evolutionary conserved checkpoint kinases, hBUB 1 and MPS 1, and the Cdc27 subunit ot the Anaphase Promoting Complex (APC). We will examine the mechanism by which hBUB 1 specifies the assembly of subdomain of the kinetochore that consists of checkpoint proteins hBUBR1, MAD1, MAD2 and Cdc20. These studies will be critical for understanding the dynamic nature of the interactions between checkpoint proteins and kinetochores. We will characterize the role of the hMPS 1 kinase in the mitotic checkpoint pathway by examining its importance at kinetochores and in transducing the signal from unattached kinetochores to the APC. Lastly, we have made the novel discovery that the Cdc27 subunit of the APC facilitates checkpoint inhibition of the APC in both humans and budding yeast. Our analysis of how Cdc27 accomplishes this provides a unique """"""""bottoms- up"""""""" approach to study the signaling pathway that allows cells with even a single unattached chromosome from prematurely exiting mitosis. PERFORMANCE KEY PERSONNEL. Start with Principal Name SITE(S) (organization, city, state) Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA See instructions. Use continuation pages as neededto provide the required information Investigator. List all other key personnel in alphabetical order, last name first. Organization in the format shown below. Role on Project Yen, Timothy J. Institute for Cancer Research, Fox Chase Cancer Center Guacci, Vincent A. Institute for Cancer Research, Fox Chase Cancer Center Li, Yueh-chun Institute for Cancer Research, Fox Chase Cancer Center Marcus, Adam Institute for Cancer Research, Fox Chase Cancer Center Melloy, Patricia Institute for Cancer Research, Fox Chase Cancer Center Principal Investigator Co-Investigator Postdoctoral Associate Postdoctoral Associate Postdoctoral Associate Disclosure Permission Statement ApOlicable to SBIPJSTTR Only. See instructions, r3 Yes [] No PHS 398 (Rev. 05/01) Page ___ Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b, Form Page 2 2 Principal Investigator/Program Director (Last, first,middle): YEN, Timothy L The nameof theprincipalinvestigatorprogradmirectormustbeprovidedat thetop ofeachprintedpageandeachcontinuationpage. RESEARCH GRANT TABLE OF CONTENTS Page Numbe_ 1 Face Page ....................................................................................................................................................................................... 2 Description,

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA099423-03S1
Application #
7452811
Study Section
Special Emphasis Panel (ZRG1-CDF-4 (02))
Program Officer
Spalholz, Barbara A
Project Start
2003-07-07
Project End
2007-12-31
Budget Start
2005-07-01
Budget End
2007-12-31
Support Year
3
Fiscal Year
2007
Total Cost
$74,582
Indirect Cost
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Huang, Haomin; Fletcher, Lynda; Beeharry, Neil et al. (2008) Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res 68:3724-32
Eytan, Esther; Braunstein, Ilana; Ganoth, Dvora et al. (2008) Two different mitotic checkpoint inhibitors of the anaphase-promoting complex/cyclosome antagonize the action of the activator Cdc20. Proc Natl Acad Sci U S A 105:9181-5
Sudakin, Valery; Yen, Timothy J (2007) Targeting mitosis for anti-cancer therapy. BioDrugs 21:225-33
Zuccolo, Michela; Alves, Annabelle; Galy, Vincent et al. (2007) The human Nup107-160 nuclear pore subcomplex contributes to proper kinetochore functions. EMBO J 26:1853-64
Zhang, Rugang; Liu, Song-tao; Chen, Wei et al. (2007) HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol 27:949-62
Huang, Haomin; Feng, Jie; Famulski, Jakub et al. (2007) Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J Cell Biol 177:413-24
Liu, Song-Tao; Rattner, Jerome B; Jablonski, Sandra A et al. (2006) Mapping the assembly pathways that specify formation of the trilaminar kinetochore plates in human cells. J Cell Biol 175:41-53
Mollinari, Cristiana; Kleman, Jean-Philippe; Saoudi, Yasmina et al. (2005) Ablation of PRC1 by small interfering RNA demonstrates that cytokinetic abscission requires a central spindle bundle in mammalian cells, whereas completion of furrowing does not. Mol Biol Cell 16:1043-55
Yen, Tim J; Kao, Gary D (2005) Mitotic checkpoint, aneuploidy and cancer. Adv Exp Med Biol 570:477-99